Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Navamedic AS
AS
Active
Org 920969836
Henrik Ibsens Gate 100, 0255
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2018 · 8 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Navamedic AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
269M
202M
134M
67M
0M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 201M
201M
2022
2023: 216M (+7% vs 2022)
216M
+7%
2023
2024: 202M (-6% vs 2023)
202M
-6%
2024
EBITDA
NOK millions
97M
73M
49M
24M
0M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 78M
78M
2022
2023: 50M (-36% vs 2022)
50M
-36%
2023
2024: 41M (-18% vs 2023)
41M
-18%
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
201 580
215 624
200 505
0
0
Staff expenses
−0
−0
−0
−0
−0
EBITDA
41 202
50 426
78 248
−23
−110
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
41 202
50 426
78 248
−23
−110
Net financials
8 109
3 707
−738
0
0
Profit before tax
49 311
54 133
77 510
−23
−110
Tax
10 858
11 909
16 935
−0
74
Net profit
38 453
42 223
60 575
−23
−184
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
197 089
234 362
200 044
135
159
Equity
144 760
133 987
124 185
130
154
Long-term debt
0
0
0
0
0
Short-term debt
52 330
100 375
75 858
5
5
Total debt
52 330
100 375
75 858
5
5
Financial ratios
5-year trend
EBITDA margin
20,4 %
This company
15,8 %
Market median
This company
Market median
29% above market
2020
2024
Equity ratio
73,4 %
This company
38,2 %
Market median
This company
Market median
92% above market
2020
2024
Return on equity
26,6 %
This company
18,4 %
Market median
This company
Market median
45% above market
2020
2024
Net profit margin
19,1 %
This company
8,1 %
Market median
This company
Market median
136% above market
2020
2024
Asset turnover
1,02×
This company
1,12×
Market median
This company
Market median
9% below market
2020
2024
Debt / equity
0,36×
This company
0,62×
Market median
This company
Market median
42% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Navamedic AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
